Page 24 - CIBER-BBN2016-ENG

Industrial Transfer Programme
Coordinator: Simó Schwartz Navarro
In 2016 two Spanish patents, one European patent and four PCT extensions were applied for and three patents went into national stages, being validated in several countries. The grant of two Spanish and one European patents has been received and four licence contracts have been signed.
Five CIBER-BBN transfer projects were undertaken, with the support of the five companies financing
these. Another of these projects has ended, due to reaching the end of the planned performance period, obtaining the results set at the start. The company and the groups of the CIBER-BBN continue to develop the technology of this last project, extending their cooperation by means of two projects with external financing. A new call for transfer projects is made, the start of two new projects being planned after signing the required R+D contracts with the companies.
Service provision contracts have been signed with seven consultancy companies for boosting technology transfer. These consultants have met the research groups of the CIBER-BBN to get to know their technologies, which they have valued for their transfer potential. Contacts have been made with some companies and investors to find out their interest in our technologies by means of cooperation and/or investment in our projects, creation of spin-off companies or acquisition of licences for our patents. As
a result of this strategic action a project was submitted for the FIPSE (Fundación para la Innovación y la Prospectiva de Salud en España) call. Contacts with companies for possible cooperation in projects are also open.
Translational Research Programme
Coordinator: Ramón Mangues Bafalluy
Aware of the fact that bringing our technologies closer to the clinical world is a task where there is still room for improvement, encounters with clinical staff have been held in the framework of the CIBER-BBN 2016 sessions to promote knowledge of the problems being faced by doctors. Three thematic forums were specifically arranged: on cancer, infections in implants and neurological diseases. In a first part of each forum, three doctors specialising in each field set forth their vision from the standpoint of clinical practice. Later on there was a chance to organise individualised debates at round tables between researchers and doctors which were highly enriching for both groups.
Cooperative projects in respiratory pathologies continued to be developed along with CIBERES and SEPAR, and work has started on defining a new cooperation call to be launched in 2017 by CIBER-BBN, CIBERER and CIBERES.
CIBER-BBN has gone on being an Interested Party in the Committee for Advanced Therapies (CAT) of the European Medicines Agency (EMA).
The call for intramural projects decided in 2016 passed 69 new cooperative projects, each of these focussing on solving a specific clinical problem. The pathologies which are tackled by cooperative research done in the framework of these projects are: cancer (24 projects), arthrosis, arthritis and bone regeneration (9), neurological and mental diseases (9), infectious diseases (6), ophthalmology (5), cardiovascular diseases (5), kidney diseases (3), ulcer healing (2), diabetes (2), implants (2), respiratory diseases (1) and rare diseases (1).
12243